	US 12,133,930 B2
	System and methods for soft-tissue augmentation
Alan G. Taylor, Memphis, TN (US); Bruce R Lawrence, Oceanside, CA (US); and Rebecca Hawkins Wahl, Escondido, CA (US)
Assigned to TheraMicro, LLC, Memphis, TN (US)
Filed by In2Bones USA, LLC, Memphis, TN (US)
Filed on May 23, 2018, as Appl. No. 15/987,732.
Claims priority of provisional application 62/510,601, filed on May 24, 2017.
Prior Publication US 2018/0339085 A1, Nov. 29, 2018
Int. Cl. A61L 27/26 (2006.01); A61L 27/02 (2006.01); A61L 27/18 (2006.01); A61L 27/20 (2006.01); A61L 27/36 (2006.01); A61L 27/54 (2006.01); A61M 5/00 (2006.01); A61M 5/178 (2006.01); A61M 5/46 (2006.01)

CPC A61L 27/26 (2013.01) [A61L 27/025 (2013.01); A61L 27/18 (2013.01); A61L 27/20 (2013.01); A61L 27/362 (2013.01); A61L 27/3666 (2013.01); A61L 27/3695 (2013.01); A61L 27/54 (2013.01); A61M 5/178 (2013.01); A61M 5/1782 (2013.01); A61M 5/46 (2013.01); A61L 2300/412 (2013.01); A61L 2400/06 (2013.01); A61L 2430/34 (2013.01); A61M 5/002 (2013.01); A61M 2210/0606 (2013.01); A61M 2210/083 (2013.01); A61M 2210/086 (2013.01)]

21 Claims

1. An injectable composition provided in a kit comprising one or more injecting elements, the kit comprising:

a needle comprising a 20 gauge or smaller,

one or more syringes comprising a plunger and a graduated barrel for measuring an amount of the injectable composition;

a first syringe and a second syringe, wherein either of the first and second syringes are pre-filled with the soft-tissue augmenting agent and the other of the syringes is pre-filled with the vehicle for the soft-tissue augmenting agent;

a syringe connector configured to facilitate coupling the first syringe with the second syringe; wherein the syringe connector places the first syringe into fluid communication with the second syringe;

wherein one or more of the injecting elements are sterile for immediate use upon unpacking the soft-tissue augmenting kit;

wherein the injectable composition comprises a soft-tissue augmenting agent; and a vehicle for the soft-tissue augmenting agent for augmenting one or more soft tissues of a human or animal; and

wherein during coupling of the first and second syringes, the soft-tissue augmenting agent may be mixed with the vehicle for the soft-tissue augmenting agent thereby fanning the injectable composition for delivery.